ZIMBABWE will exempt pharmaceutical manufacturers from paying import duty, in a bid to lower production costs and improve the sector’s competitiveness. This is part of a wider government strategy which was approved this week to bolster the sector and increase local production of essential medicines from the current US$31,5 million to US$150 million by 2025.…
Subscribe to read full article. Subscribe today